Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 80

Results For "regulatory"

1627 News Found

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
Drug Approval | March 07, 2024

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer

The validations confirm the completion of the applications and commence the scientific review process


Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
News | March 07, 2024

Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA

ANVISA issues CGMP to Concord Biotech’s Unit I


Nectar Lifesciences’ suo moto clarification on a news item
News | March 07, 2024

Nectar Lifesciences’ suo moto clarification on a news item

Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs


Dr. Mandaviya inaugurates Sadhana Nitro Chem’s Para Amino Phenol bulk drug plant
Policy | March 06, 2024

Dr. Mandaviya inaugurates Sadhana Nitro Chem’s Para Amino Phenol bulk drug plant

Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene


Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical Trials | March 03, 2024

Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease

Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg


USFDA inspects Shilpa Medicare’s bio-analytical laboratory in Hyderabad
Drug Approval | March 02, 2024

USFDA inspects Shilpa Medicare’s bio-analytical laboratory in Hyderabad

This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently


Suven announces merger of Cohance Lifesciences
News | March 01, 2024

Suven announces merger of Cohance Lifesciences

The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals


TechInvention Lifecare breaks ground of its GCMC
Biotech | February 29, 2024

TechInvention Lifecare breaks ground of its GCMC

The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy


NIA signs MoU with Department of Thai Traditional and Alternative Medicine
Policy | February 28, 2024

NIA signs MoU with Department of Thai Traditional and Alternative Medicine

MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine


Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Startup | February 27, 2024

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups